These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 28258889)
1. Geriatric Assessment as a Predictor of Tolerance, Quality of Life, and Outcomes in Older Patients With Head and Neck Cancers and Lung Cancers Receiving Radiation Therapy. VanderWalde NA; Deal AM; Comitz E; Stravers L; Muss H; Reeve BB; Basch E; Tepper J; Chera B Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):850-857. PubMed ID: 28258889 [TBL] [Abstract][Full Text] [Related]
2. Clinician-observed and patient-reported toxicities and their association with poor tolerance to therapy in older patients with head and neck or lung cancer treated with curative radiotherapy. Moon DH; Chera BS; Deal AM; Wang Y; Muss HB; VanderWalde NA J Geriatr Oncol; 2019 Jan; 10(1):42-47. PubMed ID: 29903673 [TBL] [Abstract][Full Text] [Related]
3. Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life. Pottel L; Lycke M; Boterberg T; Pottel H; Goethals L; Duprez F; Van Den Noortgate N; De Neve W; Rottey S; Geldhof K; Buyse V; Kargar-Samani K; Ghekiere V; Debruyne PR Eur J Cancer Care (Engl); 2014 May; 23(3):401-12. PubMed ID: 24467393 [TBL] [Abstract][Full Text] [Related]
4. The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort study. Verdonck-de Leeuw IM; Buffart LM; Heymans MW; Rietveld DH; Doornaert P; de Bree R; Buter J; Aaronson NK; Slotman BJ; Leemans CR; Langendijk JA Radiother Oncol; 2014 Mar; 110(3):422-8. PubMed ID: 24582144 [TBL] [Abstract][Full Text] [Related]
5. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study. Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564 [TBL] [Abstract][Full Text] [Related]
6. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination. List MA; Siston A; Haraf D; Schumm P; Kies M; Stenson K; Vokes EE J Clin Oncol; 1999 Mar; 17(3):1020-8. PubMed ID: 10071297 [TBL] [Abstract][Full Text] [Related]
7. Association of Deficits Identified by Geriatric Assessment With Deterioration of Health-Related Quality of Life in Patients Treated for Head and Neck Cancer. de Vries J; Bras L; Sidorenkov G; Festen S; Steenbakkers RJHM; Langendijk JA; Witjes MJH; van der Laan BFAM; de Bock GH; Halmos GB JAMA Otolaryngol Head Neck Surg; 2021 Dec; 147(12):1089-1099. PubMed ID: 34673914 [TBL] [Abstract][Full Text] [Related]
8. Impact on Health-Related Quality of Life of Induction Chemotherapy Compared With Concurrent Cisplatin and Radiation Therapy in Patients With Head and Neck Cancer. Adkins D; Ley J; Oppelt P; Gay HA; Daly M; Paniello RC; Jackson R; Pipkorn P; Rich J; Zevallos J; Trinkaus K; Thorstad W Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):e123-e131. PubMed ID: 31147146 [TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of Vulnerability Assessment in Patients with Primary Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiation Therapy. Chou WC; Chang PH; Chen PT; Wang HM; Yeh KY; Lu CH; Hung YS; Tung-Chieh Chang J; Tsang NM; Ho YW; Chen SY; Lee SH; Hung CY; Wang LJ; Liao KC; Lin CH; Tang WR; Lin YC Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):602-611. PubMed ID: 31987971 [TBL] [Abstract][Full Text] [Related]
10. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Christianen ME; Schilstra C; Beetz I; Muijs CT; Chouvalova O; Burlage FR; Doornaert P; Koken PW; Leemans CR; Rinkel RN; de Bruijn MJ; de Bock GH; Roodenburg JL; van der Laan BF; Slotman BJ; Verdonck-de Leeuw IM; Bijl HP; Langendijk JA Radiother Oncol; 2012 Oct; 105(1):107-14. PubMed ID: 21907437 [TBL] [Abstract][Full Text] [Related]
11. Influence of Chinese medicine on weight loss and quality of life during radiotherapy in head and neck cancer. Huang YH; Chen JL; Yang SH; Liu GH; Chang KP; Tsang NM Integr Cancer Ther; 2013 Jan; 12(1):41-9. PubMed ID: 22553254 [TBL] [Abstract][Full Text] [Related]
12. Patient-Reported Toxicity and Quality-of-Life Profiles in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy or Chemoradiation. Van den Bosch L; van der Laan HP; van der Schaaf A; Oosting SF; Halmos GB; Witjes MJH; Oldehinkel E; Meijer TWH; van den Hoek JGM; Steenbakkers RJHM; Langendijk JA Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):456-467. PubMed ID: 34048816 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of chemoradiation for head and neck cancer in an older patient population. VanderWalde NA; Meyer AM; Deal AM; Layton JB; Liu H; Carpenter WR; Weissler MC; Hayes DN; Fleming ME; Chera BS Int J Radiat Oncol Biol Phys; 2014 May; 89(1):30-7. PubMed ID: 24725687 [TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients. Sprave T; Verma V; Fabian A; Rühle A; Baltas D; Grosu AL; Nicolay NH Strahlenther Onkol; 2022 Nov; 198(11):1008-1015. PubMed ID: 35833963 [TBL] [Abstract][Full Text] [Related]
15. G-8 indicates overall and quality-adjusted survival in older head and neck cancer patients treated with curative radiochemotherapy. Pottel L; Lycke M; Boterberg T; Pottel H; Goethals L; Duprez F; Rottey S; Lievens Y; Van Den Noortgate N; Geldhof K; Buyse V; Kargar-Samani K; Ghekiere V; Debruyne PR BMC Cancer; 2015 Nov; 15():875. PubMed ID: 26553007 [TBL] [Abstract][Full Text] [Related]
16. Adverse events associated with concurrent chemoradiation therapy in patients with head and neck cancer. Givens DJ; Karnell LH; Gupta AK; Clamon GH; Pagedar NA; Chang KE; Van Daele DJ; Funk GF Arch Otolaryngol Head Neck Surg; 2009 Dec; 135(12):1209-17. PubMed ID: 20026818 [TBL] [Abstract][Full Text] [Related]
17. Impact of concomitant chemotherapy on outcomes of radiation therapy for head-and-neck cancer: a population-based study. Gupta S; Kong W; Booth CM; Mackillop WJ Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):115-21. PubMed ID: 24331657 [TBL] [Abstract][Full Text] [Related]
18. Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer. de Vries J; Bras L; Sidorenkov G; Festen S; Steenbakkers RJHM; Langendijk JA; Witjes MJH; van der Laan BFAM; de Bock GH; Halmos GB Oral Oncol; 2020 Dec; 111():105020. PubMed ID: 33045628 [TBL] [Abstract][Full Text] [Related]
19. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity. Hoebers F; Heemsbergen W; Moor S; Lopez M; Klop M; Tesselaar M; Rasch C Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e111-8. PubMed ID: 21362581 [TBL] [Abstract][Full Text] [Related]
20. Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial. Sio TT; Atherton PJ; Pederson LD; Zhen WK; Mutter RW; Garces YI; Ma DJ; Leenstra JL; Rwigema JM; Dakhil S; Bearden JD; van der Veen SJ; Ganti AK; Schild SE; Miller RC Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):686-696. PubMed ID: 30395904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]